| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.23 | 5e-05 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.001 |